Women fighting for the health of girls and boys

Share this article

While A non-partisan demonstration against the transition of girls and boys and in support of their incarcerated father will be held in Vancouver on Saturday, April 10 (you see here) for speaking out against the hormone therapy administered to his 14-year-old daughter in the UK The Times returns again to the health risks of "non-compliant" minors treated with puberty blockers, after thousands of disastrously administered therapies, see here (authorized therapies Also in Italy, but in our country almost all the media and politics ignore the problem).

Women have great merit in this fight for risk disclosure: gender critical feminism also keeps the bodies of girls and boys at the center of its attention.

—————————————————————————————————————

The alarm for the Health impacts of administration of puberty blockers and cross-sex hormones to young people struggling with gender identity has prompted them to ask for a review of their use in Scotland.

The National Institute for Health and Care Excellence (Nice) said that existing studies on the drugs had been carried out on samples too small and “subject to bias and confusion.”

There is also research published by British Medical Journal who described how children on puberty blockers at the end of treatment, at age 16, suffered a reduced growth in height and bone strength.

The Scottish Intercollegiate Guidelines Network (Sign), which provides clinical advice to the NHS, was invited to review the studies, for the concern that eight-year-olds may be prescribed these drugs.

It should be one national scandal, we hope that the next elections will force our politicians to reflect on their responsibilities and that this medical experiment will be stopped immediately, pending a complete review" he has declared Trina Budge, which he directs For Women Scotland.

A worried woman who was told her daughter was suffering from gender dysphoria said: “The conclusions are quite overwhelming and demonstrate that it is an experiment. Anyone can suggest a problem to Sign for further investigation, so I'll ask them to check out Nice's review “.

THE puberty blockers, known scientifically as gonadotropin-releasing hormone (GnRH) analogues, they are prescribed to young people with gender dysphoria – distress caused by a discrepancy between their “perceived” gender and their sex at birth. They act on the brain to block the increase in sex hormones – estrogen and testosterone – that accompanies puberty.

The effects of the drugs were touted in Scotland as "fully reversible", but last year NHS Greater Glasgow and Clyde withdrew their gender dysphoria leaflet and apologized after an outcry that the potential long-term effects had not been clarified.

The Nice findings, published last week, were commissioned by NHS England to support an independent study by Hilary Cass, a pediatric consultant, into gender identity services for children and young people.

Nineteen separate studies were examined, including nine that looked at the impact of puberty blockers on dysphoria, mental health problems – such as depression, anger and anxiety – and recipients' quality of life. Nice, which provides guidance and advice to improve health and social care, said: “The quality of the evidence underlying these findings offers very low certainty.". It found that the evidence on the clinical effectiveness and safety of cross-sex hormones was also of “very low” quality, adding: “Any potential benefit of gender-affirming hormones must be weighed against the largely unknown long-term safety profile of these treatments in children and adolescents with gender dysphoria“.

Neither review includes recommendations and both constitute advice, rather than formal guidance.

In February, however, a study published in the British Medical Journal warned that children ages 12 to 15 who were prescribed puberty blockers experienced reduced growth in height and bone strength after treatment ended at the age of 16. The findings were based on a study of 44 children treated at the Tavistock and Portman NHS Trust, which runs a gender identity service.

Last December, in one case brought by Keira Bell against the Tavistock and Portman NHS Trust, the High Court ruled that under-16s could only consent to puberty blockers if truly able to “understand the nature of the treatment. But in a move that likely partially reverses that ruling, the court ruled last month that parents can allow their children to receive puberty blockers without seeking approval from judges.

original article here


Share this article
Scroll to Top